Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) is critical for urologist. Histological grade provides significant prognostic information, especially for prediction of progression. Currently, the 1973 and the 2004 WHO classification co-exist. Which system is better for predicting rumor recurrence and progression still a matter for debate.0.0001, log-rank test), while a significant overlap was observed between PUNLMP and LG plots using the 2004 WHO grading system(p = 0.616, log-rank test).Both the 1973 WHO and the 2004 WHO Classifications are effective in predicting tumor progression in Non-muscle invasive bladder cancer, while the 1973 WHO Classification is more suitable for predicting tumor recurrence
<p>Multivariate analyses of WHO 1973 classification and other clinical parameters inferences to pred...
Objective: Papillary urothelial neoplasm of low malignant potential (PUNLMP) and stage TaG1 non-musc...
Objectives: The clinical management of non-muscle-invasive urothelial cell carcinoma of the bladder ...
Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) is critical f...
Background: Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) i...
Objectives To compare the prognostic value of the World Health Organization (WHO) 1973 and 2004 clas...
Two classifications for bladder cancer grade are widely used; the World Health Organization (WHO) 19...
Item does not contain fulltextBACKGROUND: In the current European Association of Urology (EAU) non-m...
BACKGROUND: The European Association of Urology (EAU) prognostic factor risk groups for non-muscle-i...
Background: The European Association of Urology (EAU) prognostic factor risk groups for non–muscle-i...
Aims: To compare the 1973 WHO and the 2004/2016 WHO grading systems in patients with urothelial carc...
BACKGROUND: Grading of noninvasive papillary urinary bladder carcinoma (PUC) is routinely performed ...
The key points of the latest World Health Organization (WHO) classification of non-invasive urotheli...
Objectives. To investigate the relation of the World Health Organization/International Society of Ur...
<p>Multivariate analyses of WHO 1973 classification and other clinical parameters inferences to pred...
Objective: Papillary urothelial neoplasm of low malignant potential (PUNLMP) and stage TaG1 non-musc...
Objectives: The clinical management of non-muscle-invasive urothelial cell carcinoma of the bladder ...
Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) is critical f...
Background: Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) i...
Objectives To compare the prognostic value of the World Health Organization (WHO) 1973 and 2004 clas...
Two classifications for bladder cancer grade are widely used; the World Health Organization (WHO) 19...
Item does not contain fulltextBACKGROUND: In the current European Association of Urology (EAU) non-m...
BACKGROUND: The European Association of Urology (EAU) prognostic factor risk groups for non-muscle-i...
Background: The European Association of Urology (EAU) prognostic factor risk groups for non–muscle-i...
Aims: To compare the 1973 WHO and the 2004/2016 WHO grading systems in patients with urothelial carc...
BACKGROUND: Grading of noninvasive papillary urinary bladder carcinoma (PUC) is routinely performed ...
The key points of the latest World Health Organization (WHO) classification of non-invasive urotheli...
Objectives. To investigate the relation of the World Health Organization/International Society of Ur...
<p>Multivariate analyses of WHO 1973 classification and other clinical parameters inferences to pred...
Objective: Papillary urothelial neoplasm of low malignant potential (PUNLMP) and stage TaG1 non-musc...
Objectives: The clinical management of non-muscle-invasive urothelial cell carcinoma of the bladder ...